RIGL
Rigel Pharmaceuticals, Inc. · Healthcare · Biotechnology
Momentum inputs (comparable managers):
holder breadth +30.0% ·
share flow +30.0% ·
net new positions +20.0%
— formula
Broad accumulation — rising shares across more holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q4 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 72 | -2 | 9.47M | $370.29M | +3 | −5 |
| Q1 2026 | 77 | -10 | 11.13M | $301.00M | — | −10 |
| Q4 2025 | 86 | +1 | 11.49M | $491.92M | +1 | — |
| Q3 2025 | 18 | +3 | 6.87M | $194.53M | +3 | — |
| Q2 2025 | 12 | +2 | 4.47M | $83.70M | +2 | — |
| Q1 2025 | 7 | -1 | 1.55M | $27.81M | +2 | −3 |
| Q4 2024 | 8 | +4 | 1.41M | $23.66M | +5 | −1 |
| Q3 2024 | 3 | -2 | 554.02K | $8.97M | — | −2 |
| Q2 2024 | 5 | — | 605.71K | $4.98M | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Geode Capital Management ✦ (passive) | 402.05K | +0.6% | $6.76M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 2 | Geode Capital Management ✦ (passive) | 402.05K | +0.6% | $6.76M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 3 | State Street Global Advisors ✦ (passive) | 380.51K | — | $6.40M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | Renaissance Technologies ✦ | 299.71K | +111.1% | $5.04M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 5 | Norges Bank ✦ (passive) | 129.51K | New | $2.18M | 0.0% | New | 1 | SEC ↗ |
| 6 | Millennium Management ✦ | 70.43K | New | $1.18M | 0.0% | New | 1 | SEC ↗ |
| 7 | Two Sigma Investments ✦ | 60.91K | New | $1.02M | 0.0% | New | 1 | SEC ↗ |
| 8 | Wellington Management ✦ | 34.98K | New | $588,414 | 0.0% | New | 1 | SEC ↗ |
| 9 | Wellington Management ✦ | 34.98K | New | $588,414 | 0.0% | New | 1 | SEC ↗ |
| 10 | Citadel Advisors ✦ | 28.41K | New | $477,873 | 0.0% | New | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| Norges Bank | $2.18M | 0.0% |
| Millennium Management | $1.18M | 0.0% |
| Two Sigma Investments | $1.02M | 0.0% |
| Wellington Management | $588,414 | 0.0% |
| Wellington Management | $588,414 | 0.0% |
| Citadel Advisors | $477,873 | 0.0% |
Exited
| T. Rowe Price | $201,000 | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 146 holders, 15.81M shares, $391.97M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.